The Importance of Western Blotting in Medical Science
Western blot delivers both confirmatory results in the field of research and diagnostic testing. Lyme is the tick-borne disease in the region of North America. According to study published in 2018, by Carnegie Mellon University sates that Lyme disease is expected to rise in United States. Reason for rise in Lyme disease is the climate change. Various studies have shown western blot IgM has 94-96% of specificity towards the patient with clinical symptom of Lyme disease.
The increasing investment in the sector is likely to encourage the growth of the industry during the forecast period. In addition, the industry is also expected to grow due to support of government that has initiated programs to increasing the professionals. The collaboration of the countries such China and Japan with the foreign entities are expected to grow the industry during the forecast period.
Western blot is used in the confirmatory test for HIV followed by ELISA test. Western blot was specifically gold standard for the diagnosis of HIV-1 infection. According to data published on the site of HIV.gov in 2016, approximately 38,700 people were newly infected by HIV. Therefore, owing to the above mentioned factors it is expected that the industry is likely to grow during the forecast period.
PROFILING KEY PLAYERS:
Thermo Fisher Scientific Inc., Merck KGaA, GENERAL ELECTRIC, Cell Signaling Technology, Inc., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., LI-COR, Inc., OriGene Technologies, Inc., Rockland Immunochemicals Inc., Abcam Plc.
Western blot is the major analytical tool to assess the molecular function in basic cell biology research, drug discovery and pathology. There has been significant improvement in the technical aspect of western blot which has led to improvement in efficiency, reproducibility, ease of use. For example, iBind Western Systems launched by Thermo Fisher Scientific Corporation which is and automated western blot device which does not require continuous monitoring.
Further the turnaround time is reduced compared to traditional method where it involves the various steps and four hours for final results. In iBind all the solution is required to be loaded rest all process is automated by sequential lateral flow technology (SLF) which does not require any electricity or batteries. The significant advantage provided by automated western blot system will contribute in the growth of the western blot industry.